JP2003504052A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003504052A5 JP2003504052A5 JP2001509486A JP2001509486A JP2003504052A5 JP 2003504052 A5 JP2003504052 A5 JP 2003504052A5 JP 2001509486 A JP2001509486 A JP 2001509486A JP 2001509486 A JP2001509486 A JP 2001509486A JP 2003504052 A5 JP2003504052 A5 JP 2003504052A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/351,778 US7589069B1 (en) | 1999-07-12 | 1999-07-12 | Replication-competent anti-cancer vectors |
| US09/351,778 | 1999-07-12 | ||
| PCT/US2000/018971 WO2001004282A2 (en) | 1999-07-12 | 2000-07-12 | Replication-competent anti-cancer vectors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003504052A JP2003504052A (ja) | 2003-02-04 |
| JP2003504052A5 true JP2003504052A5 (enExample) | 2005-12-22 |
| JP4361708B2 JP4361708B2 (ja) | 2009-11-11 |
Family
ID=23382352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001509486A Expired - Fee Related JP4361708B2 (ja) | 1999-07-12 | 2000-07-12 | 複製−コンピテント抗癌ベクター |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US7589069B1 (enExample) |
| EP (1) | EP1196616B1 (enExample) |
| JP (1) | JP4361708B2 (enExample) |
| AT (1) | ATE286139T1 (enExample) |
| AU (1) | AU780613B2 (enExample) |
| CA (1) | CA2378586C (enExample) |
| DE (1) | DE60017141T2 (enExample) |
| ES (1) | ES2231281T3 (enExample) |
| WO (1) | WO2001004282A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7589069B1 (en) * | 1999-07-12 | 2009-09-15 | Saint Louis University | Replication-competent anti-cancer vectors |
| CA2439185A1 (en) | 2001-02-23 | 2002-09-06 | Novartis Ag | Vector constructs |
| US8163892B2 (en) * | 2002-07-08 | 2012-04-24 | Oncolys Biopharma, Inc. | Oncolytic virus replicating selectively in tumor cells |
| US20040213764A1 (en) * | 2003-03-28 | 2004-10-28 | William Wold | Adenovirus replication-competent vectors expressing trail |
| CN1871034B (zh) * | 2003-07-09 | 2011-07-06 | 亨利福特保健系统公司 | 用新型腺病毒治疗癌症的方法和组合物 |
| US7815902B2 (en) | 2003-07-09 | 2010-10-19 | Henry Ford Health System | Methods and compositions for cancer therapy using a novel adenovirus |
| WO2005049094A1 (en) * | 2003-11-13 | 2005-06-02 | Advantagene, Inc. | A mixed complementary viral vector for gene therapy |
| WO2008136213A1 (ja) * | 2007-04-27 | 2008-11-13 | Oncolys Biopharma Inc. | 放射線増感増強剤 |
| US8696544B2 (en) | 2009-02-05 | 2014-04-15 | Coloplast A/S | Minimally invasive adjustable support |
| WO2011146885A2 (en) * | 2010-05-21 | 2011-11-24 | Virxsys Corporation | Compositions and methods for lentiviral expression of apoa-1 or variants thereof using spliceosome mediated rna trans-splicing |
| SG11201507393TA (en) | 2013-03-14 | 2015-10-29 | Salk Inst For Biological Studi | Oncolytic adenovirus compositions |
| ES2899913T3 (es) | 2014-09-24 | 2022-03-15 | Salk Inst For Biological Studi | Virus tumorales oncolíticos y métodos de uso |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| EP3390645B1 (en) | 2016-02-23 | 2022-09-14 | Salk Institute for Biological Studies | Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics |
| AU2017375633C1 (en) | 2016-12-12 | 2023-04-27 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
| WO2018111902A1 (en) | 2016-12-12 | 2018-06-21 | Multivir Inc. | Methods and compositions comprising viral gene therapy and an immune checkpoint inhibitor for treatment and prevention of cancer and infectious diseases |
| CA3094329A1 (en) | 2018-03-19 | 2020-02-20 | Multivir Inc. | Methods and compositions comprising tumor suppressor gene therapy and cd122/cd132 agonists for the treatment of cancer |
| BR112020019942A2 (pt) * | 2018-04-09 | 2021-01-26 | Salk Institute For Biological Studies | composições de adenovírus oncolítico com propriedades de replicação aprimoradas |
| WO2021113644A1 (en) | 2019-12-05 | 2021-06-10 | Multivir Inc. | Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5846945A (en) | 1993-02-16 | 1998-12-08 | Onyx Pharmaceuticals, Inc. | Cytopathic viruses for therapy and prophylaxis of neoplasia |
| US5631236A (en) * | 1993-08-26 | 1997-05-20 | Baylor College Of Medicine | Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk |
| US6254862B1 (en) | 1997-03-03 | 2001-07-03 | Calydon, Inc. | Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| US6197293B1 (en) * | 1997-03-03 | 2001-03-06 | Calydon, Inc. | Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| US6627190B2 (en) * | 1999-07-12 | 2003-09-30 | Saint Louis University | Recombinant adenovirus vectors that are replication-competent in tert-expressing cells |
| US7589069B1 (en) * | 1999-07-12 | 2009-09-15 | Saint Louis University | Replication-competent anti-cancer vectors |
-
1999
- 1999-07-12 US US09/351,778 patent/US7589069B1/en not_active Expired - Fee Related
-
2000
- 2000-07-12 DE DE60017141T patent/DE60017141T2/de not_active Expired - Lifetime
- 2000-07-12 WO PCT/US2000/018971 patent/WO2001004282A2/en not_active Ceased
- 2000-07-12 ES ES00975153T patent/ES2231281T3/es not_active Expired - Lifetime
- 2000-07-12 EP EP00975153A patent/EP1196616B1/en not_active Expired - Lifetime
- 2000-07-12 CA CA2378586A patent/CA2378586C/en not_active Expired - Fee Related
- 2000-07-12 AU AU13244/01A patent/AU780613B2/en not_active Ceased
- 2000-07-12 AT AT00975153T patent/ATE286139T1/de not_active IP Right Cessation
- 2000-07-12 JP JP2001509486A patent/JP4361708B2/ja not_active Expired - Fee Related
-
2005
- 2005-10-13 US US11/249,873 patent/US7608255B2/en not_active Expired - Fee Related
-
2009
- 2009-09-16 US US12/561,016 patent/US8658610B2/en not_active Expired - Fee Related